Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phenyl Pyrrolidine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel biocatalytic route for chiral pyrrolidine intermediates. High yield, mild conditions, cost-effective supply for Trk inhibitor manufacturing.
Patent CN119219679A reveals a novel alcohol base-induced borylation method eliminating noble metals. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN114075557B reveals enzymatic synthesis for high-purity Larotrectinib intermediate. Achieve cost reduction and scalable supply chain reliability.
Advanced optical resolution process for 2-methyl-1-(4-trifluoromethylphenyl)-3-pyrrolidine-1-propanone. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN118909993A reveals a high-activity imine reductase mutant for green synthesis. Achieves >99% optical purity and high space-time yield for reliable supply.
Patent CN111302997A reveals a streamlined one-pot method for Raatinib intermediates, offering significant cost and waste reduction for API manufacturing.
Novel metal-catalyzed synthesis offers mild conditions and high yields for phenyl pyrrolidine intermediates, ensuring supply chain stability and cost efficiency.
Patent CN104447507B reveals efficient synthesis for solar cell acceptor materials, offering supply chain stability and cost-effective manufacturing solutions for global buyers.
Patent CN104592163A enables cost-effective chiral pyrrolidine synthesis. Enhances supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN117025699A reveals a chemo-enzymatic route for Larotinib intermediates. Achieve high ee values and reduced costs with scalable pharmaceutical manufacturing solutions.
Patent CN111057729B reveals enzymatic synthesis for high-purity Larotrectinib intermediates. Discover cost-effective, scalable biocatalytic manufacturing solutions.
Patent CN111057729A details a green enzymatic route for Larotretinib intermediates, offering high ee values and cost reduction in API manufacturing.
Novel enzyme process for chiral amine intermediate. High purity, mild conditions, scalable for pharma manufacturing.
Novel base-catalyzed racemization of larotrectinib intermediate enables recycling of S-isomer, reducing costs and waste for API manufacturing.
Patent CN112250611B reveals a novel Friedel-Crafts route for Larotrectinib intermediates. Achieve high purity and cost reduction in API manufacturing with scalable chemistry.
Novel metal catalyzed tandem synthesis offers mild conditions and high yields for pharmaceutical intermediates, ensuring supply chain reliability and cost efficiency.
Novel synthesis of Trk inhibitor intermediate CN104672121B offers higher yield and safety. Reliable supply chain partner for scalable API intermediate manufacturing with cost efficiency.
Novel route for (R)-2-(2,5-difluorophenyl)pyrrolidine avoids noble metals, offering cost-effective API manufacturing solutions.
Innovative catalyst-free synthesis method eliminates hazardous reagents and reduces process steps while achieving high optical purity for critical oncology drug intermediates
Patent CN115872905A enables high-purity API intermediate production with TON=100,000, reducing manufacturing costs and supply chain lead time through green catalysis.